USPH U S PHYSICAL THERAPY INC /NV
Services-Health Services · NYSE · SEC CIK 885978 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY10.4%
TTM net income YoY-32.5%
TTM EPS YoY-156.1%
Revenue 3-yr CAGR12.3%
Net income 3-yr CAGR-0.1%
Margins
Gross margin18.8%
Operating margin9.1%
Net margin3.6%
FCF margin8.2%
EBITDA margin11.7%
Returns
ROE6.5%
ROA2.4%
ROIC (approx.)9.1%
Asset turnover0.67x
Leverage & solvency
Liabilities / assets39.2%
Debt / equity0.57x
Current ratio1.42x
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.95x
Accruals ratio-4.7%
Payout ratio—
Capex / revenue2.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $780.99M | $671.35M |
| Gross profit | $149.69M | $123.92M |
| SG&A expense | $69.26M | $58.29M |
| Operating income | $86.68M | $62.99M |
| Pretax income | $77.81M | $60.21M |
| Income tax | $19.81M | $14.61M |
| Net income | $39.58M | $31.42M |
| EBITDA | $109.07M | $81.67M |
| EPS (basic) | 1.42 | 1.84 |
| EPS (diluted) | 1.42 | 1.84 |
| Dividends declared per share | 1.80 | 1.76 |
| Weighted avg. shares (diluted) | 15.18M | 15.06M |
| Balance sheet | ||
| Cash & equivalents | $35.57M | $41.36M |
| Receivables | $64.25M | $59.04M |
| Current assets | $139.99M | $137.58M |
| PP&E, net | $35.65M | $32.14M |
| Goodwill | $692.39M | $667.15M |
| Intangibles | $172.86M | $179.31M |
| Total assets | $1.20B | $1.17B |
| Current liabilities | $139.04M | $116.28M |
| Short-term debt | $9.87M | $11.00M |
| Long-term debt | $152.59M | $142.53M |
| Total debt | $162.46M | $153.53M |
| Total liabilities | $433.81M | $408.42M |
| Shareholders' equity | $476.43M | $488.93M |
| Net debt | $126.89M | $112.17M |
| Cash flow statement | ||
| Operating cash flow | $75.06M | $74.94M |
| Capital expenditure | $14.07M | $9.19M |
| Free cash flow | $60.99M | $65.75M |
| Investing cash flow | -$36.71M | -$149.45M |
| Financing cash flow | -$44.14M | -$36.95M |
| Depreciation & amortization | $22.39M | $18.68M |
| Stock-based compensation | $8.27M | $7.82M |
| Dividends paid | $27.36M | $26.54M |
| Share buybacks | $5.57M | $0 |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.